Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes by Ricky K. Hsu, Jennifer S. Fusco, Cassidy E. Henegar, Vani Vannappagari, Andrew Clark, Laurence Brunet, Philip C. Lackey, Gerald Pierone, Gregory P. Fusco

Get full text

HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial by Michael B. Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Jennifer S. Fusco, Christine Uranaka, Quateka Cochran, Monica Palma, Tammeka Evans, Carl Millner, Gregory P. Fusco

Get full text

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study by Karam Mounzer, Ricky Hsu, Jennifer S. Fusco, Laurence Brunet, Cassidy E. Henegar, Vani Vannappagari, Chris M. Stainsby, Mark S. Shaefer, Leigh Ragone, Gregory P. Fusco

Get full text

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study by Anthony M. Mills, Laurence Brunet, Jennifer S. Fusco, Michael B. Wohlfeiler, Cindy P. Garris, Alan K. Oglesby, Joseph M. Mrus, Philip C. Lackey, Gregory P. Fusco

Get full text

Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial by Michael B. Wohlfeiler JD, MD, AAHIVS, Laurence Brunet PhD, Quateka Cochran MSNEd, RN, ACRN, Jennifer S. Fusco BS, Ricky K. Hsu MD, Gregory P. Fusco MD, MPH

Get full text

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort by Michael G. Sension, Laurence Brunet, Ricky K. Hsu, Jennifer S. Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Lewis McCurdy, Michael B. Wohlfeiler, Gregory P. Fusco

Get full text